Skip to content
naulon

Not checkedNot checked for notices yet.

Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates

Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan and 27 more

Nature Communications · 2022

doi:10.1038/s41467-022-30835-1 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

There is limited real-world evidence for the effectiveness of the BBIBP-CorV (Sinopharm) vaccine against severe COVID-19 disease. Here, the authors use data from Abu Dhabi and estimate effectiveness at 80% against hospitalization; 86% against critical care admission and 84% against death.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.